SCHEMBL29451485

SCHEMBL29451485

CN1CCN(C)S(=O)(=O)c2cc(NC(=O)Cn3ncc(F)cc3=O)ccc21

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 6/20 0.46
▸ WDR77 Q9BQA1 6/20 0.46
▸ MAPT P10636 4/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ PTK2 Q05397 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ CRHBP P24387 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ CRHR2 Q13324 1/20 0.37
▸ NPC1 O15118 3/20 0.37
▸ MITF O75030 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ PAX8 Q06710 2/20 0.36
▸ RIOK1 Q9BRS2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ TP53 P04637 2/20 0.35
▸ POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29451486 0.86 PRMT5 (0.47) PRMT5WDR77MAPTKDM4EL3MBTL1
SCHEMBL29451674 0.83 PRMT5 (0.59) PRMT5WDR77MAPTL3MBTL1MEN1
SCHEMBL29452008 0.81 KDM4E (0.39) PRMT5WDR77MAPTKDM4EPTK2
SCHEMBL29451784 0.72 PRMT5 (0.44) PRMT5WDR77MAPTKDM4EL3MBTL1
SCHEMBL29451823 0.70 KDM4E (0.40) PRMT5WDR77MAPTKDM4EPTK2
SCHEMBL29451753 0.69 PRMT5 (0.68) PRMT5WDR77MAPTKDM4EL3MBTL1
SCHEMBL29451915 0.67 PRMT5 (0.46) PRMT5WDR77MAPTKDM4EL3MBTL1
SCHEMBL29452187 0.67 PRMT5 (0.46) PRMT5WDR77MAPTKDM4EL3MBTL1
SCHEMBL29451417 0.64 KMO (0.44) PRMT5WDR77MAPTKDM4EL3MBTL1
SCHEMBL29451286 0.62 CA12 (0.47) MAPTKDM4EMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022032144-A1 SUBSTRATE ADAPTOR INHIBITORS OF PRMT5 AND USES THEREOF THE BROAD INSTITUTE, INC. (US) 2022-02-10 — — WO disclosed
Send feedback